Recro Pharma Inc. | Mutual Funds
Mutual Funds that own Recro Pharma Inc.
Vanguard Total Stock Market Index Fund
443,396
2.14%
0
0%
07/31/2018
iShares Russell 2000 ETF
369,457
1.78%
-198
0.01%
09/06/2018
Vanguard Extended Market Index Fund
202,068
0.98%
100
0%
07/31/2018
iShares Russell 2000 Growth ETF
175,899
0.85%
0
0.01%
09/06/2018
Schwab Small Cap Equity Fund
150,709
0.73%
0
0.14%
06/30/2018
106,367
0.51%
106,367
0.09%
09/20/2017
Managers Cadence Emerging Companies Fund
103,409
0.5%
0
0.44%
06/29/2018
DFA US Small Cap Portfolio
62,023
0.3%
0
0%
04/30/2018
Fidelity Spartan Extended Market Index Fund
59,391
0.28%
0
0%
07/31/2018
iShares Micro Cap ETF
47,096
0.23%
0
0.03%
09/06/2018
| Address |
490 Lapp Road
Malvern Pennsylvania 19355
United States
|
|
Employees
|
- |
| Website |
http://www.recropharma.com |
| Updated |
07/08/2019 |
| Recro Pharma, Inc. is a pharmaceutical company, which engages in the research and development of non-opioid therapeutics for the treatment of acute post operative pain. It operates through the Acute Care, and Contract Development and Manufacturing (CDMO) business segment. The Acute Care segment focuses on developing innovative products for hospital and related settings. |
